Abstract
Nanoparticles are attractive agents for cancer therapy because of two unique properties. First is their ability to accumulate in tumor tissue. This is due in part to their unique pharmacokinetics allowing minimal renal filtration and evading uptake by the reticuloendothelial system. Second is their high surface-to-volume ratios for carrying various sensors, therapeutics and targeting species for passive or active targeting of cancer cells.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
